India proposes immediate suspension of drug manufacturing licences over quality failures
India proposes immediate suspension of drug manufacturing licences for medicines failing government quality tests, tightening oversight and strengthening action against drugmakers.
Attributed summary
India proposes immediate suspension of drug manufacturing licences for medicines failing government quality tests, tightening oversight and strengthening action against drugmakers.
Read the original report — BusinessLine
Storywire publishes attributed summaries for discoverability. Full reporting remains with the original publisher — we do not republish restricted full text.